Sort   by:  
 Page size 
UnknownRecovery of glioblastoma cells derived from patients after a decade of cryopreservation for drug response studies.
Not available
S-EPMC12606342 | biostudies-literature
UnknownGLIMMERS: glioma molecular markers exploration using long-read sequencing.
Not available
S-EPMC11087932 | biostudies-literature
UnknownTumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
Not available
S-EPMC3930173 | biostudies-literature
UnknownOutcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
Not available
S-EPMC3403724 | biostudies-literature
UnknownPhase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.
Not available
S-EPMC3018944 | biostudies-literature
UnknownMetronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
Not available
S-EPMC2795427 | biostudies-literature
UnknownExploiting nanopore sequencing for characterization and grading of IDH-mutant gliomas.
Not available
S-EPMC10711254 | biostudies-literature
UnknownBevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.
Not available
S-EPMC3493761 | biostudies-literature
UnknownOligosarcomas, IDH-mutant are distinct and aggressive.
Not available
S-EPMC8742817 | biostudies-literature
Sort   by:  
 Page size